- Home
- SES vs ABEO Comparison
SES vs ABEO Comparison
Compare SES & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SES | ABEO |
|---|---|---|
| Founded | 2012 | 1974 |
| Country | United States | United States |
| Employees | 215 | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 384.1M | 307.5M |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | SES | ABEO |
|---|---|---|
| Price | $1.08 | $5.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $4.00 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 8.3M | 918.3K |
| Earning Date | 04-23-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.16 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,998,000.00 |
| Revenue This Year | $53.90 | $1,024.31 |
| Revenue Next Year | $111.26 | $145.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 258.18 |
| 52 Week Low | $0.80 | $4.00 |
| 52 Week High | $3.73 | $7.54 |
Technical Indicators
Market Signals| Indicator | SES | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 44.60 | 51.58 |
| Support Level | $1.05 | $5.24 |
| Resistance Level | $1.40 | $5.64 |
| Average True Range (ATR) | 0.11 | 0.23 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 8.75 | 47.52 |
Price Performance
Historical ComparisonAbout SES SES AI Corporation
SES AI Corp is a developer and manufacturer of rechargeable battery technologies and battery materials for Energy Storage Systems (ESS), Urban Air Mobility (UAM), drones, robotics, electric vehicles (EVs), and other applications. For Enery Storage Systems, the company supplies hardware and software solutions with battery health and safety management software powered by its AI-based platform, Molecular Universe. Additionally, it offers battery materials and high-energy and power-density Li-Metal and Li-ion cells, which can be used for drones, UAM, robotics, and EV applications. The company also offers access to Molecular Universe as a software product. Currently, it generates maximum revenue from the development of Li-ion and Li-Metal battery materials as per the client's specifications.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.